JOURNAL ARTICLE

Universidade Federal de Sao Paulo (UNIFESP) Reports Findings in Tetrahydrocannabinol (Adverse clinical effects associated with the use of synthetic cannabinoids: A systematic review).

  • Published In: Psychology & Psychiatry Journal, 2025. P. 429 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

A recent study conducted by Universidade Federal de Sao Paulo (UNIFESP) in Brazil focused on the adverse clinical effects associated with the use of synthetic cannabinoids. The research highlighted severe outcomes such as psychosis, dependence, seizures, and cardiovascular complications linked to synthetic cannabinoids, which are significantly more potent than natural cannabis. The study emphasized the urgent need for targeted public health policies to address the risks associated with synthetic cannabinoid use and improve medical management. Further controlled studies are recommended to understand the underlying mechanisms of these clinical effects and their pharmacological basis. [Extracted from the article]

Additional Information

  • Source:Psychology & Psychiatry Journal. 2025/05, p429
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2025
  • ISSN:1944-2718
  • Accession Number:185192858
  • Copyright Statement:Copyright of Psychology & Psychiatry Journal is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.